Objective. Short sleep duration and insomnia have been linked to higher pain and an increased risk of developing chronic pain, but relatively little research has examined the contribution of sleep disordered breathing (SDB) to pain. This study examined the unique contributions of SDB and insomnia to chronic pain.
Introduction
High rates of comorbidity between chronic pain and sleep problems have been consistently observed. Half of patients with insomnia have chronic pain, and between 50% and 88% of patients with chronic pain have sleep disturbance [1, 2] . Sleep disordered breathing (SDB) and insomnia represent the most common sleep disorders, affecting millions of individuals in the United States. Estimates of prevalence vary due to differences in research diagnostic criteria, but studies have shown that approximately 2% to 4% of adults have some form of SDB, most commonly obstructive sleep apnea (OSA). [3] The prevalence of insomnia with associated daytime impairment among adults is approximately 10% to 15%, though 33% to 50% of adults report some insomnia symptoms [4] .
The relationship of pain with short sleep duration or insomnia has been characterized fairly extensively. Data suggest that there is a bidirectional relationship but that sleep is a stronger and more reliable predictor of pain [1] . The accumulation of research during recent years supports the conclusion that insufficient or poor sleep serves as an exacerbating factor for most types of acute and chronic pain. However, relatively little is known regarding how SDB impacts chronic pain. Furthermore, it is unclear how pain is related to different types (i.e., obstructive vs central apnea) or features of SDB. Thus far, results have been mixed in terms of whether SDB is related to increased or decreased pain, perhaps owing to the fact that SDB involves both fragmentation and hypoxemia, which may exert mixed effects on pain sensitivity.
Cross-sectionally, the presence of OSA has been linked to higher odds of pain [5] , and prospective studies have shown that the presence of OSA predicts a greater likelihood of developing temporomandibular disorder [6] and bladder pain [7] . Similarly, individuals with fibromyalgia [8] and musculoskeletal pain [9] appear to be at higher risk for OSA compared with pain-free controls. In terms of specific sleep features, lower arterial oxygen saturation (SaO 2 nadir) has been associated with higher risk of pain [10] and higher sensitivity during fibromyalgia tender point testing [11] .
In contrast, several studies have found that SDB is either not associated with pain [12] or is associated with decreased pain [13, 14] . A recent study showed mixed results, such that more severe apnea predicted higher pain intensity but lower pain sensitivity (forearm pressure pain threshold) the next morning [15] . Results of this study also suggested a long-term hypoalgesic effect of SDB, as more severe apnea-hypopnea index (AHI) and desaturation were associated with lower pain intensity over the preceding day and six months.
Treatment studies have been mixed but provide some support for the impact of improved SDB on pain. A retrospective examination of veterans using continuous positive airway pressure (CPAP) did not find reductions in ether pain intensity or opioid consumption after 12 months [16] . However, in pain-free patients with OSA, treatment with PAP has been shown to decrease experimental pain sensitivity [17, 18] .
Given conflicting findings in the literature on SDB and pain, there is not yet a clear understanding of how sleep apnea and its component features interact with chronic pain. Additionally, although SDB and insomnia frequently co-occur in clinical samples, they are usually studied in isolation. However, they both present with some degree of fragmented and shortened sleep, and it remains unknown whether disruptions associated with each disorder have similar effects on pain.
The present study aimed to address these gaps in the literature by examining the relationship of pain to both SDB-and insomnia-related sleep disturbance. We examined the unique contributions of these sleep disorders to pain as well as the relationship of pain to specific symptoms of SDB and different types of fragmentation. We hypothesized that-controlling for total sleep time-sleep fragmentation would be positively related to pain intensity and nocturnal hypoxemia would be negatively related to pain intensity. We further hypothesized that-compared with individuals with either SDB or insomnia in isolation-individuals with both sleep disorders would be more likely to have chronic pain and report higher pain intensity. Given limited prior research linking SDB to pain, no hypothesis was made as to whether SDB or insomnia would more strongly predict pain.
Methods

Participants
Patients referred to the University of Florida (UF) Health Sleep Center for overnight polysomnography (PSG) were recruited to participate in this study. Individuals were eligible for participation if they met the following criteria: 1) 18 years of age or older, 2) scheduled to undergo diagnostic PSG (i.e., measurement only, no PAP administration) or split-night PSG (i.e., PAP administered during the latter portion of the night) at the Sleep Center, 3) access to a computer with internet in order to complete daily sleep diaries, and 4) able to read and write English. Split-night PSG was allowed in this study based on previous research showing that there is no significant difference in the AHI as measured in the first two or three hours of sleep compared with the total night [19, 20] . Individuals were excluded from participation for the following reasons: 1) previous and/or current treatment with PAP or 2) undergoing treatment PSG (i.e., PAP administered the entire night). Based on a power analysis using effect sizes from extant literature, we planned to recruit approximately 120 participants.
Individuals were not included/excluded on the basis of pain type or duration; the study aimed to sample a broad range of pain types, and the hypotheses did not specify different predictions based on pain type. Similarly, potential participants could present with any type of sleep complaint as the study sought to examine continuous measures of sleep-related respiration and fragmentation that may be found in a variety of disorders.
Measures
Data for this study were taken from measures routinely administered to patients undergoing PSG at the UF Health Sleep Center. Participants were also asked to complete additional measures on the night of the PSG and two weeks of sleep diaries following the PSG, as described below. was also performed during the day following PSG in order to assess for narcolepsy. MSLT raw data were not used for the present study, though the results of MSLT were used by physicians in determining patient diagnoses.
Sleep Questionnaires
Clinic questionnaires provided information on the participant's typical sleep schedule as well as nighttime and daytime symptoms. Study participants were also asked to complete the Insomnia Severity Index (ISI) on the night of their PSG. The ISI is a brief measure used for insomnia screening and assessing treatment outcomes [21] . Adequate internal consistency has been demonstrated among patients referred to a sleep disorders center (Cronbach's a ¼ 0.74) [21] and among primary care patients (Cronbach's a ¼ 0.92) [22] .
Sleep Diaries
Insomnia was further assessed via two weeks of sleep diaries, in keeping with suggested guidelines [4] . In order to ease participant burden and encourage timely completion, participants received a daily email with a link to complete the sleep diary using the REDCap web application. The daily sleep diaries yielded the following variables, which were used in subsequent analyses: time in bed, total sleep time, sleep onset latency, wake time after sleep onset, sleep efficiency (the percentage of time in bed spent sleeping), number of awakenings, and sleep quality rating (1 ¼ "very poor" to 5 ¼ "excellent"). Participants were also asked to record any prescribed or over-the-counter (OTC) sleep medications taken.
The presence or absence of chronic insomnia was determined from sleep diary data. Based on the International Classification of Sleep Disorders, 3rd edition [23] , and quantitative criteria [24] , participants were diagnosed with insomnia if they reported difficulty initiating or maintaining sleep 1) lasting more than 30 minutes [24] , 2) occurring at least three nights per week [23, 24] , and 3) having persisted for at least three months [23] , along with 4) a complaint of daytime distress or dysfunction due to insomnia [23, 24] . The last criterion was determined based on responses to the ISI (i.e., any endorsement of daytime interference or of worry/distress about sleep).
Pain
On the daily online survey, participants provided pain intensity and unpleasantness ratings and recorded any prescribed or OTC pain medications taken. On the night of the PSG, participants were asked to complete the Medical College of Virginia (MCV) Pain Questionnaire [25, 26] . The MCV provides visual analog scale ratings of highest, lowest, and usual pain intensity ("no sensation" to "the most intense sensation imaginable") and pain unpleasantness ("not bad at all" to "the most intense bad feeling imaginable") during the past week. The MCV also solicits ratings of the impact of pain on the respondent's life and negative emotions related to pain (depression, anxiety, frustration, anger, fear). In addition to the MCV, participants indicated whether they had any chronic pain conditions, the name of the condition(s), and the location(s) of their pain during the last three months.
Procedures
All procedures were approved by the UF Institutional Review Board. Recruitment took place at the UF Health Sleep Center during the evening when patients arrived for overnight PSG. A technologist asked the patient for permission to be approached by a researcher, who described the study and provided time for the patient to review the informed consent form. Individuals who consented to participate were asked to complete questionnaires (described above) and to complete daily sleep/ pain diaries online during the next two weeks. Compensation was provided to participants after all procedures were completed.
Statistical Analyses
Analyses were performed using SPSS v. 24.0 (SPSS Inc., Chicago, IL, USA). For participants who underwent split-night PSG (N ¼ 23), only data from the diagnostic portion of the PSG were used (e.g., the AHI reflects the value during the untreated portion of the night, not the value during PAP titration). All enrolled participants (N ¼ 105) were included in analyses when possible, though missing data precluded the inclusion of some individuals in certain analyses described below. Specifically, one participant did not complete PSG and eight did not complete any daily diaries. Three individuals partially completed daily diaries (three, seven, and 11 days, respectively) and were included in corresponding analyses.
Analyses were designed to examine how SDB and different types of sleep fragmentation were related to pain, including whether the two prominent characteristics of SDB (i.e., fragmentation and nocturnal hypoxemia) were uniquely related to pain. These aims were examined with a single hierarchical regression with the outcome variable of average pain intensity obtained via daily diaries. The predictors entered into the regression were obtained from PSG. In order to control for total sleep time, it was entered in the first predictor block of the regression. The second block added measures of nocturnal hypoxemia (minimum SaO 2 , amount of time spent at or below 88% SaO 2 ), SDB-specific fragmentation (AHI), and other types of fragmentation (spontaneous arousals, periodic leg movement [PLM] arousals). Prior research has shown that the AHI correlates strongly (r ¼ 0.97, P < 0.0001) with the number of respiratory arousals [27] .
Additionally, we examined the relationship of pain to the diagnostic categories of SDB and insomnia. First, a one-way analysis of variance compared the pain intensity (mean obtained from sleep diaries) of individuals with no sleep diagnosis and those meeting diagnostic criteria for OSA, insomnia, or comorbid OSA/insomnia. Second, chi-square was used to compare the likelihood of individuals in those same diagnostic categories having chronic pain (i.e., self-report of pain more days than not during the preceding three months).
Results
Participant Characteristics
A total of 155 individuals were determined to be potentially eligible for the study. Of those, 130 were approached to determine eligibility (25 declined to be approached by a researcher), 105 were enrolled in the study (14 declined due to lack of interest or time, and 11 were not eligible because of prior PAP use [N ¼ 4], inability to use or access a computer with internet [N ¼ 6], or inability to read [N ¼ 1]), and 94 participants completed all study procedures. Of the 105 enrolled participants, 41.90% were male and 58.10% were female. The age of participants ranged from 18 to 81 years, with a mean age of 43.83 years (SD ¼ 16.52 years). Participants selfidentified as belonging to the following racial groups: 70.48% white, 17.14% black/African American, and 5.71% Asian/Asian American. Hispanic/Latino ethnicity was endorsed by 5.71%. The majority (54.29%) of participants reported that they were currently working outside the home, and 14.29% reported being unable to work due to disability. Slightly less than half (48.57%) reported being currently married.
Sleep Characteristics
Sleep Disordered Breathing
Diagnoses of sleep-related breathing disorders and other sleep disorders were made by physicians at the UF Health Sleep Center. OSA represented the most common diagnosis, comprising 52.38% of the sample (N ¼ 55). A substantial proportion of individuals-many of whom were referred for suspected sleep apneawere given no diagnosis (N ¼ 36, 34.29%). See Table 1 for a complete list of diagnoses given to participants by physicians following PSG (and MSLT, if applicable).
Insomnia
Physicians infrequently made a diagnosis of insomnia (N ¼ 5, 4.76%) based on a patient's PSG results. This is perhaps not surprising, given standards of practice dictating that insomnia is best evaluated through a detailed sleep history and sleep diaries rather than PSG [4] . Using sleep diaries and other self-report data obtained 
Pain Characteristics
Participants indicated the body regions in which they had pain more days than not over the preceding three months. On this basis, 80.00% of the sample was determined to have chronic pain in at least one body region. This determination was made solely on the basis of frequency and duration, without regard to the intensity of pain. 
Contributions of Fragmentation and Hypoxemia to Pain
A hierarchical regression was conducted to determine whether sleep fragmentation and nocturnal hypoxemia contributed uniquely to pain intensity (above and beyond total sleep time). We first examined whether other potential covariates were significantly correlated with the outcome, pain intensity. Age was not significantly correlated with pain intensity (P > 0.05) though BMI was (r ¼ 0.21, P < 0.05). There was a significant sex difference in pain intensity (t(95) ¼ -2.75, P < 0. [M ¼ 9.15 minutes, SD ¼ 24.58]) were not significant predictors (see Table 3 ). Table 4 provides a correlation matrix for these variables.
Risk of Pain Across Sleep Disorders
Differences in Pain Intensity by Sleep Diagnosis
We sought to determine whether there were significant differences in pain intensity (mean obtained from daily diaries) among individuals with OSA, insomnia, comorbid OSA/insomnia, or no sleep diagnosis. We first examined whether potential covariates were significantly correlated with the outcome, pain intensity, in this subsample of individuals falling into the above categories. Neither age nor BMI was significantly correlated with pain intensity (Ps > 0.05). However, there was a significant sex difference in pain intensity (t(86) ¼ -2.57, After controlling for sex, there was a significant effect of diagnostic group on pain intensity (F(3, 83) ¼ 5.14, P < 0.01, g 2 p ¼ 0.16). Bonferroni-corrected post hoc comparisons showed significantly higher pain intensity in the comorbid group compared with all other groups (Ps < 0.05). Covariate-adjusted means are reported in Table 5 .
Likelihood of Chronic Pain by Sleep Diagnosis
The prevalence of chronic pain was 81.25% among the subset of participants (N ¼ 96) with OSA (N ¼ 42), insomnia (N ¼ 9), comorbid OSA/insomnia (N ¼ 13), or no sleep disorder (N ¼ 32). The prevalence of chronic pain within diagnostic groups was as follows: OSA ¼ 76.19%, insomnia ¼ 88.89%, comorbid OSA/insomnia ¼ 100%, and no diagnosis ¼ 78.13%. Based on a 
Discussion
Contributions of Sleep Characteristics and Disorders to Pain
This study investigated the unique contributions of sleep disorders and their distinct features, particularly symptoms of SDB, to pain. There was a high prevalence of chronic pain in this sample (80.00%), and-perhaps in part due to this high base rate of chronic pain-the likelihood of having chronic pain did not differ by sleep diagnosis. However, controlling for participant sex, individuals with comorbid OSA/insomnia reported an average pain intensity that was 20 points (out of 100) higher than individuals with insomnia or no diagnosis and 28 points higher than those with OSA. This magnitude of difference is likely to be noticeable and meaningful to patients [28] , and as such would have implications for clinical care (discussed below). The results of this study thus indicate that there is a high likelihood that any patient being referred for sleep evaluation has chronic pain and that patients who meet criteria for both OSA and insomnia may have significantly higher pain than their counterparts with a single sleep disorder.
A small number of prior studies have found mixed associations of SDB with pain intensity or experimental pain sensitivity, including indications that nocturnal hypoxemia and SDB-related fragmentation may differ in their relationships to pain. Our study found no relationship between SDB-related variables (AHI, SaO 2 nadir, time at or below 88% SaO 2 ) and clinical pain intensity in a sample of individuals referred to a sleep clinic. Additionally, measures of nonapnea fragmentation (spontaneous arousals, PLM arousals) were not related to pain intensity.
Clinical Implications
In this sample of patients referred to a sleep center, most were diagnosed with OSA (52.38%). Although physicians diagnosed only 4.76% with insomnia, the inclusion of sleep diaries in this study allowed us to classify 20.95% as meeting criteria for chronic insomnia. Of particular interest for this study, we found that 12.38% of participants had comorbid OSA/insomnia. Although these results may only generalize to other sleep clinics and not the general population, our rates of comorbidity fall within the ranges previously reported [3, 29] . Specifically, we found that 23.64% of participants with OSA also met criteria for insomnia and 59.09% of those with insomnia also met criteria for OSA. Most individuals with insomnia were not identified as such through the standard sleep center evaluation, suggesting the potential importance of more thorough insomnia assessment through either screening measures or sleep diaries when feasible. Effective treatments exist for both OSA and insomnia, but it is important to identify whether both disorders are present in an individual as this may complicate treatment. Initial and middle insomnia are associated with poorer PAP adherence [30, 31] , and it may therefore be necessary to treat insomnia concurrently. Additionally, insomnia comorbid with OSA is likely to require treatment as previous research has shown that insomnia (with the possible exception of middle insomnia) tends to persist and may even emerge (in the case of late insomnia) with PAP treatment [30] .
The high frequency of chronic pain (80.00%) in a population referred for sleep evaluation is striking but nonetheless aligns with what is already known about the high rates of chronic pain in patients with sleep disorders [1] . Musculoskeletal pain (28.57%) and chronic headaches (24.76%) were the most common types of pain reported. In keeping with population norms [32] , the back was the most frequently reported location of chronic pain (48.57%). The high frequency of chronic pain in this sample is of clinical importance for treating sleep disorders as pain intensity has been shown to predict PAP nonadherence [16] . In the present study, the majority of patients diagnosed with OSA had chronic pain (81.82%). Moreover, individuals with insomnia in addition to OSA had significantly higher average pain intensity than individuals with only OSA. Thus, while pain may be a barrier to PAP adherence in many patients with OSA, adherence is likely to be especially challenging among individuals with comorbid OSA/insomnia. Improved management of a comorbid pain condition would therefore be indicated when pain impedes adherence to treatment for a sleep disorder. Similarly, initial or concurrent treatment of comorbid insomnia may aid adherence to OSA treatment, though this remains to be tested in clinical trials [29] .
Limitations and Future Directions
The results of this study may apply only to the population from which they were drawn-a tertiary sleep center-and may not generalize to the broader population or even to patients seen in other medical settings.
Specific chronic pain diagnoses used to characterize the sample were solicited from participants and were not verified by providers or with medical records. However, diagnoses were collected only in order to characterize the sample, and determination of the presence of chronic pain was accomplished through separate questions ascertaining whether the participant had experienced persistent pain in any body part over the preceding three months. This study did not explore whether associations between sleep features and pain are modified by the type of pain condition. In our broad clinical sample, we did not find evidence that SDBrelated fragmentation and hypoxemia are associated with pain intensity. However, future researchers may be interested in exploring the relationships between SDB characteristics and pain in specific pain populations, such as individuals with spinal conditions, who are noted to have higher rates of OSA than the general population [33] . Such investigations may shed light on the mechanisms of the sleep-pain interaction.
The present study did not find associations of pain to specific SDB symptoms, but it did reveal that individuals who had comorbid OSA/insomnia had more intense pain than individuals with either sleep disorder in isolation. This population deserves further study in order to better understand what mechanisms might account for the higher pain associated with comorbid OSA/insomnia. Additionally, an important area for future research concerns the clinical care of patients with comorbid OSA/insomnia. Treatment may be complicated by the presence of a comorbid sleep disorder, and future research should aim to develop empirically based guidelines regarding whether comorbid OSA and insomnia are best treated concurrently or in succession, including the optimal order for treatment, which may depend on the type of insomnia (i.e., initial, middle, or late).
Conclusions
Although the likelihood of chronic pain did not differ by sleep disorder, individuals with comorbid OSA/insomnia had significantly higher average pain than their counterparts with OSA, insomnia, or no sleep diagnosis. This suggests that the most severe pain is likely to be found in individuals whose sleep is disturbed in a greater number of ways-at least when looking at the most common sleep disorders-rather than a specific relationship between pain and type of sleep disturbance. The majority of participants reported chronic pain, and this investigation found that measures of sleep fragmentation and hypoxemia were not related to pain intensity among individuals referred to a sleep center. This study highlights the importance of identifying individuals with comorbid OSA/insomnia as effective treatment of their sleep problems may be complicated by the existence of comorbid sleep disorders [30, 31] and chronic pain [16] , which is likely to be present in this population.
